ARCHIVES

In Brief: NCI To Move Todaro’s Lab to FCR; Cinnamyl Anthranilate Was Carciogenic In Bioassay

This article is from The Cancer Letter archive.

Vol. 06 No. 13 | March 28, 1980

Download PDF Visit The Full Archive

Related Articles

October issue of Business & Regulatory Report (8-page issue).

November 2, 2002

Trials Could Start Earlier If Model Contract Language Adopted, NCI and CEO Roundtable Say.

December 12, 2008

Guest Editorial: Learning from the Power Morcellation Fiasco: Government Must Do More to Regulate Devices

September 12, 2014

Advisors Voted For Provenge Approval Despite Fundamental Flaws In Trials.

April 13, 2007

Advanced Ovarian Cancer Responds To Irofulven In Phase II Studies

October 26, 2001

UT Southwestern Simmons Cancer Center received $50 million from Simmons family.

November 4, 2005